Cargando…

HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors

BACKGROUND: Nearly 30% of neuroendocrine tumors (NETs) have evidence of immunohistochemical (IHC) expression of estrogen (ER) and/or progesterone (PR) receptors. Therefore, targeting ER/PR may offer an effective NET-directed treatment to select patients. METHODS: We conducted a multicenter Simon two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barros, Milton J., Strosberg, Jonathan, Al-Toubah, Taymeyah, de Jesus, Victor Hugo F., Durant, Lais, Mello, Celso A., Felismino, Tiago C., De Brot, Louise, Taboada, Rodrigo G., Donadio, Mauro D., Riechelmann, Rachel P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Advances in Diagnosis and Treatment of Neuroendocrine Neoplasms
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387775/ https://www.ncbi.nlm.nih.gov/pubmed/37529158 http://dx.doi.org/10.1177/17588359231186041

Ejemplares similares

A systematic review of therapeutic strategies in gastroenteropancreatic grade 3 neuroendocrine tumors
por: Donadio, Mauro D., et al.
Publicado: (2023)

Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms
por: Bourdeleau, Pauline, et al.
Publicado: (2023)

The postoperative prognosis of skip-N2 metastasis is favorable in small-cell lung carcinoma patients with pathological N2 classification: a propensity-score-adjusted retrospective multicenter study
por: Wu, Lei-Lei, et al.
Publicado: (2023)

Diagnostic value of whole-mount crypt analysis of ileal biopsy specimens for the patients with familial small intestinal neuroendocrine tumors
por: Sei, Yoshitatsu, et al.
Publicado: (2023)

Future therapeutic strategies in the treatment of extrapulmonary neuroendocrine carcinoma: a review
por: Robinson, Matthew D., et al.
Publicado: (2023)

A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours
por: Perrier, Marine, et al.
Publicado: (2023)

Intra-individual qualitative and quantitative comparison of [(68)Ga]Ga-DOTATATE PET/CT and PET/MRI
por: Lens, Géraldine, et al.
Publicado: (2023)

Preliminary experience with a new institutional tumor board dedicated to patients with neuroendocrine neoplasms
por: Trikalinos, Nikolaos A., et al.
Publicado: (2022)

What is the role of checkpoint inhibitors in neuroendocrine neoplasms?
por: Al-Toubah, Taymeyah, et al.
Publicado: (2020)

Chemotherapy in Neuroendocrine Tumors
por: Das, Satya, et al.
Publicado: (2021)

Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors
por: Al-Toubah, Taymeyah, et al.
Publicado: (2022)

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy
por: Minczeles, N.S., et al.
Publicado: (2021)

Update on Histological Reporting Changes in Neuroendocrine Neoplasms
por: Bräutigam, Konstantin, et al.
Publicado: (2021)

The Role of Patient Support Groups in Neuroendocrine Neoplasms
por: Kolarova, Teodora, et al.
Publicado: (2021)

New Directions in Imaging Neuroendocrine Neoplasms
por: Refardt, Julie, et al.
Publicado: (2021)

New Developments in Gastric Neuroendocrine Neoplasms
por: Exarchou, Klaire, et al.
Publicado: (2022)

Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?
por: Cope, Jack, et al.
Publicado: (2022)

How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?
por: Niederle, Bruno, et al.
Publicado: (2021)

Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
por: Luchini, Claudio, et al.
Publicado: (2021)

What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?
por: Ratnayake, Gowri M., et al.
Publicado: (2022)

Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
por: Al-Toubah, Taymeyah, et al.
Publicado: (2023)

Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1
por: Al-Sharefi, Ahmed, et al.
Publicado: (2019)

Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
por: Rico, Karen, et al.
Publicado: (2021)

Severe hyponatremia as presenting symptom of small cell lung carcinoma
por: Stevchevska, Aleksandra, et al.
Publicado: (2023)

A rare case of ectopic Cushing syndrome presenting with weight loss
por: Şah Ünal, Fatma Tuğçe, et al.
Publicado: (2023)

A case of malign insulinoma diagnosed with liver metastasis
por: Şehit Kara, Canan, et al.
Publicado: (2023)

Pancreatic tumor with hepatic metastases secreting vasoactive intestinal polypeptide: Treatment options and long-term follow-up results
por: Sözen, Mehmet, et al.
Publicado: (2023)

Cancer, an introduction /
por: Creasey, William A.
Publicado: (1981)

Posterior Reversible Encephalopathy Syndrome in ALL
por: Millichap, J. Gordon
Publicado: (2015)

MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study
por: Dwabe, Sami, et al.
Publicado: (2021)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

Recent Advancements, Limitations, and Future Perspectives of the use of Personalized Medicine in Treatment of Colon Cancer
por: Dey, Amit, et al.
Publicado: (2023)

Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Li, Shuofeng, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio and Early Tumor Shrinkage as Predictive Biomarkers in Unresectable Hepatocellular Carcinoma Patients Treated With Lenvatinib, PD-1 Inhibitors, in Combination With TACE
por: Qu, Shuping, et al.
Publicado: (2023)

Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence
por: Jiang, Yu, et al.
Publicado: (2023)

TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm)
por: Xiang, Zhanwang, et al.
Publicado: (2023)

A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma
por: Qing, Shuiwang, et al.
Publicado: (2023)

Simple Scoring Model Based on Enhanced CT in Preoperative Prediction of Biological Risk of Gastrointestinal Stromal Tumor
por: Wang, Yating, et al.
Publicado: (2023)

The Importance of Evaluating Serum Levels of Tumor Markers M2-PK and Inhibin A in Patients Undergoing Colonoscopy
por: Khosravi, Mahmood, et al.
Publicado: (2023)

Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis
por: Machida, Maiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pr7565hnpao3akisu14dkcvp0i